Luis A Diaz

Fulminant Myocarditis with Combination Immune Checkpoint Blockade.

J. Seidman, J. Taube, D. Roden, 2016, The New England journal of medicine.

Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.

I. Lossos, E. Mesri, S. Bhatt, 2013, The Journal of clinical investigation.

Zidovudine-based lytic-inducing chemotherapy for Epstein–Barr virus-related lymphomas

D. Dittmer, U. Bayraktar, S. Bayraktar, 2014, Leukemia & lymphoma.